Journal of Vaccine Research 2024, Vol.14, No.2, 40-53 http://medscipublisher.com/index.php/jvr 52 Oftung F., Næss L.M., Laake I., Stoloff G., and Pleguezuelos O., 2022, FLU-v, a broad-spectrum influenza vaccine, induces cross-reactive cellular immune responses in humans measured by dual IFN-γ and granzyme B ELISpot assay, Vaccines, 10(9): 1528. https://doi.org/10.3390/vaccines10091528 PMid:36146606 PMCid:PMC9505334 Pica N., and Palese P., 2013, Toward a universal influenza virus vaccine: prospects and challenges, Annual Review of Medicine, 64(1): 189-202. https://doi.org/10.1146/annurev-med-120611-145115 PMid:23327522 Pillet S., Couillard J., Trépanier S., Poulin J.F., Yassine-Diab B., Guy B., Ward B., and Landry N., 2019, Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate-two randomized Phase II clinical trials in 18 to 49 and≥ 50 years old adults, PloS one, 14(6): e0216533. https://doi.org/10.1371/journal.pone.0216533 PMid:31166987 PMCid:PMC6550445 Qiao Y., Li S., Jin S., Pan Y., Shi Y., Kong W., and Shan Y., 2022, A self-assembling nanoparticle vaccine targeting the conserved epitope of influenza virus hemagglutinin stem elicits a cross-protective immune response, Nanoscale, 14(8): 3250-3260. https://doi.org/10.1039/D1NR08460G PMid:35157751 Rappazzo C.G., Watkins H.C., Guarino C.M., Chau A., Lopez J.L., DeLisa M.P., Leifer C., Whittaker G., and Putnam D., 2016, Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB/c mice, Vaccine, 34(10): 1252-1258. https://doi.org/10.1016/j.vaccine.2016.01.028 PMid:26827663 Rimmelzwaan G.F., Fouchier R.A., and Osterhaus A.D., 2007, Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development, Current Opinion in Biotechnology, 18(6): 529-536. https://doi.org/10.1016/j.copbio.2007.11.002 PMid:18083548 Sakala I.G., Honda-Okubo Y., Li L., Baldwin J., and Petrovsky N., 2021, A M2 protein-based universal influenza vaccine containing Advax-SM adjuvant provides newborn protection via maternal or neonatal immunization, Vaccine, 39(36): 5162-5172. https://doi.org/10.1016/j.vaccine.2021.07.037 PMid:34362601 Scorza F.B., Tsvetnitsky V., and Donnelly J.J., 2016, Universal influenza vaccines: shifting to better vaccines, Vaccine, 34(26): 2926-2933. https://doi.org/10.1016/j.vaccine.2016.03.085 PMid:27038130 PMCid:PMC4899887 Stadlbauer D., Zhu X., McMahon M., Turner J.S., Wohlbold T.J., Schmitz A.J., Strohmeier S., Yu W., Nachbagauer R., Mudd P., Wilson I., Ellebedy A., and Krammer F., 2019, Broadly protective human antibodies that target the active site of influenza virus neuraminidase, Science, 366(6464): 499-504. https://doi.org/10.1126/science.aay0678 PMid:31649200 PMCid:PMC7105897 Vemula S.V., Sayedahmed E.E., Sambhara S., and Mittal S.K., 2017, Vaccine approaches conferring cross-protection against influenza viruses, Expert Review of Vaccines, 16(11): 1141-1154. https://doi.org/10.1080/14760584.2017.1379396 PMid:28925296 PMCid:PMC6005355 Vogel O.A., and Manicassamy B., 2020, Broadly protective strategies against influenza viruses: universal vaccines and therapeutics, Frontiers in Microbiology, 11: 135. https://doi.org/10.3389/fmicb.2020.00135 PMid:32117155 PMCid:PMC7020694 Wang Y., Li S., Dong C., Ma Y., Song Y., Zhu W., Kim J., Deng L., Denning T., Kang S., Prausnitz M., and Wang B.Z., 2021, Skin vaccination with dissolvable microneedle patches incorporating influenza neuraminidase and flagellin protein nanoparticles induces broad immune protection against multiple influenza viruses, ACS Applied Bio Materials, 4(6): 4953-4961. https://doi.org/10.1021/acsabm.1c00240 PMid:34179728 PMCid:PMC8232372 Wei C.J., Boyington J.C., McTamney P.M., Kong W.P., Pearce M.B., Xu L., Andersen H., Rao S., Tumpey T., Yang Z., and Nabel G.J., 2010, Induction of broadly neutralizing H1N1 influenza antibodies by vaccination, Science, 329(5995): 1060-1064. https://doi.org/10.1126/science.1192517 PMid:20647428 Zhang J., Fan H.Y., Zhang Z., Zhang J., Zhang J., Huang J.N., Ye Y., and Liao M., 2016, Recombinant baculovirus vaccine containing multiple M2e and adjuvant LTB induces T cell dependent, cross-clade protection against H5N1 influenza virus in mice, Vaccine, 34(5): 622-629. https://doi.org/10.1016/j.vaccine.2015.12.039 PMid:26724200
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==